Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
This update describes a Phase 2 trial evaluating paclitaxel plus GM-CSF in patients with unresectable stage III or IV melanoma. The study st…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Nitrocamptothecin in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of nitrocamptothecin in patients with metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma [Phase 1, Phase 2]
A Phase I/II melanoma trial evaluating valproic acid with karenitecin has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma [Phase 2]
Phase II study of sagopilone (ZK-EPO) in metastatic melanoma completed; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma [Phase 2]
Phase 2 vaccine therapy trial for unresected stage III/IV melanoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma [Phase 1, Phase 2]
Clinical trial update reporting completion of a Phase 1/2 study evaluating photodynamic therapy in patients with stage III or stage IV melan…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery [Phase 2]
A Phase 2 clinical trial evaluated the combination of carboplatin, paclitaxel, and bevacizumab in patients with unresectable Stage IV melano…
-
CLINICAL_TRIALS trial_result · 2013-10-28Clinical Trial Update: Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)
This completed clinical trial (Study P04600) evaluated whether proactive management of side effects improves treatment compliance in melanom…
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: Viral Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of a viral therapy for metastatic melanoma completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors [Phase 2]
Phase 2 study of BI-2536 in patients with recurrent or metastatic solid tumors, including breast cancer, endometrial cancer, head and neck c…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma [Phase 1]
A Phase 1 study evaluating the combination of carboplatin and temozolomide in patients with unresectable or metastatic melanoma. The current…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma [Phase 1, Phase 2]
Phase I/II trial evaluating vaccination with antigen-loaded dendritic cells for inoperable stage III/IV melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1, Phase 2]
Clinical trial update for a phase 1/2 vaccine therapy in patients with stage IV melanoma; status is not specified in the available informati…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
Phase 1 clinical trial evaluating a vaccine therapy for metastatic melanoma is described. The trial is sponsored by Baylor Health Care Syste…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma [Phase 3]
This document reports a Phase 3 pivotal trial comparing Allovectin-7 alone versus chemotherapy in patients with stage 3 or stage 4 melanoma;…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. [Phase 1, Phase 2]
Pfizer's MEK inhibitor PD-325901 was tested in Phase 1/2 trials for advanced breast cancer, colorectal cancer, and melanoma, but the study w…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating a combination of chemotherapy and biological therapy for met…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Vaccine Therapy and Interleukin-12 in Treating Patients With Metastatic Melanoma [Phase 1, Phase 2]
This document reports the completion of Phase 1 and Phase 2 trials of a vaccine therapy combined with Interleukin-12 for metastatic melanoma…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating a multi-antigen vaccine (MAGE-3/Melan-A/gp100/NA17) with or without rhIL-12 and low-dose IL-2 in metastatic melanom…
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial of biochemotherapy with bevacizumab followed by consolidation therapy with ipilimumab in metastatic melanoma has …
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial from Dartmouth-Hitchcock Medical Center evaluated combining chemotherapy with filgrastim in patients with advanced solid tum…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: SCRI Tissue Testing Registry
This trial update indicates the SCRI Tissue Testing Registry study has been terminated; it involved patients with melanoma, myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2013-08-19Clinical Trial Update: A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma [Phase 1, Phase 2]
The document reports results from a Phase 1/2 study evaluating intetumumab alone and in combination with dacarbazine in participants with st…
-
CLINICAL_TRIALS trial_result · 2013-08-02Clinical Trial Update: Vatalanib in Treating Patients With Metastatic Cutaneous Melanoma That Cannot be Removed by Surgery [Phase 2]
Phase 2 clinical trial of vatalanib for metastatic cutaneous melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: High-Dose PEG-Intron Pharmacokinetic Study in Patients With Melanoma (Study P04831 AM2) [Phase 1]
Phase 1 pharmacokinetic study evaluating high-dose PEG-Intron in patients with melanoma completed; results were posted in 2013. The study as…